How to Treat Gout in Your Hand and Prevent Flares

Gout in the hand is treated with the same core medications used for gout anywhere else in the body: anti-inflammatory drugs to shut down an active flare, followed by urate-lowering therapy to prevent future attacks. But the hand presents unique challenges that deserve attention. Fingers and wrists have tight, crowded anatomy where even small crystal deposits can compress nerves, limit motion, and cause lasting damage if flares keep recurring. Getting treatment right early matters more here than in a roomy joint like the knee.

Why Gout Targets the Hands

Most people associate gout with the big toe, and that is where it shows up first in the majority of cases. But as the disease progresses, or sometimes right from the start, it can strike the fingers, knuckles, and wrists. Uric acid crystals form more readily at lower temperatures, and the hands tend to be cooler than the body’s core. Cold exposure promotes the crystallization of monosodium urate in synovial fluid, triggering inflammation.¹ This is one reason gout in the hands and feet is more common than in the hip or shoulder, and why flares sometimes follow cold weather or prolonged time outdoors without gloves.

When gout hits the hand, it often affects the small joints of the fingers, the wrist, or both. The swelling, redness, and intense pain can look a lot like rheumatoid arthritis or an infected joint, which makes accurate diagnosis especially important before starting treatment.

Making Sure It Really Is Gout

A swollen, painful finger joint could be gout, but it could also be rheumatoid arthritis, a bacterial infection, or calcium pyrophosphate deposition disease. Polyarticular symptoms in the hand can make it particularly hard to tell these apart.² Getting this wrong has real consequences: treating a joint infection with gout medication delays antibiotics, and treating gout as rheumatoid arthritis means unnecessary immune-suppressing drugs.

The gold standard is drawing fluid from the inflamed joint with a needle and examining it under a polarized-light microscope. If urate crystals are present, the diagnosis is confirmed. This same fluid sample can be tested for bacteria, ruling out infection at the same time.²

When joint aspiration is not practical, imaging can help. Ultrasound can pick up hallmark signs of gout in the hand, including the “double contour sign” on cartilage surfaces, visible tophus formation, and crystal deposits, and it is useful for monitoring how treatment is working over time.³ Dual-energy CT scanning is another option with about 90% sensitivity and 83% specificity for gout, though it can miss very early or first-time attacks.⁴

Treating an Acute Flare in the Hand

When a flare hits, the immediate goal is pain relief and getting the inflammation under control. Three classes of medication are used, and the choice depends on your overall health and what your body tolerates.

NSAIDs: Naproxen is a common first choice. In a head-to-head trial comparing naproxen and low-dose colchicine, both reduced pain equally over seven days, but naproxen caused significantly fewer side effects. Diarrhea occurred in about 46% of colchicine users versus 20% on naproxen.⁵ That side-effect profile makes naproxen a practical first-line option if you do not have kidney problems, stomach ulcers, or cardiovascular disease that rules out NSAIDs.
Colchicine: Low-dose colchicine works as well as high-dose colchicine for treating flares and is much safer. In trial data, low-dose colchicine had a side-effect profile similar to placebo, while high-dose colchicine caused substantially more adverse events.⁶ The key is starting it within the first twelve to twenty-four hours of a flare; the longer you wait, the less effective it becomes.
Corticosteroids: Oral prednisone or a steroid injection directly into the affected joint can calm a flare when NSAIDs and colchicine are off the table. A steroid injection into a single swollen finger joint can bring fast, targeted relief. However, formal trial evidence specifically for injected steroids in acute gout is still lacking.⁷

For a hand flare specifically, icing the joint and keeping it elevated can help with swelling. Some people find that even gripping a coffee mug becomes impossible during a bad flare, so resting the hand as much as possible speeds recovery. Do not try to “push through” hand pain by continuing to type or grip tools; that kind of mechanical stress on an inflamed joint prolongs the episode.

Urate-Lowering Therapy to Prevent Future Flares

Stopping pain during a flare is only half the job. If your uric acid levels stay high, crystals keep forming in the joints, and flares will keep coming back. The goal of long-term urate-lowering therapy is to get your blood uric acid below 6 mg/dL and keep it there.⁸ At that level, existing crystals gradually dissolve and new ones stop forming.

The two most commonly prescribed drugs are allopurinol and febuxostat, both of which work by blocking the enzyme that produces uric acid. In a 72-week trial that included patients with kidney disease, both drugs achieved uric acid targets when doses were properly adjusted. About 37% of allopurinol-treated patients had at least one flare during the observation phase, compared with about 44% on febuxostat, and the drugs were considered comparable overall.⁹ Over longer follow-up, maintaining a uric acid level below 6 mg/dL reduced the proportion of patients needing flare treatment to nearly zero and improved the status of visible tophi.¹⁰

Urate-lowering therapy should not be started in the middle of a flare. Treatment begins only after the acute attack has settled, and the dose is increased slowly, a strategy often called “start-low-go-slow.”⁸ This matters because paradoxically, starting or rapidly increasing urate-lowering drugs can itself trigger a flare. One study found that patients who started at 100 mg of allopurinol daily had roughly three times the odds of a flare in the first six months compared with those who started at a lower dose.¹¹

Prophylaxis When Starting Urate-Lowering Therapy

Because the early weeks on allopurinol or febuxostat carry a heightened flare risk, most guidelines recommend taking a low dose of colchicine or an NSAID as a preventive cushion for the first several months. The standard approach is colchicine at 0.5 mg once or twice daily, or naproxen 250 mg twice daily, continued for up to six months. Low-dose prednisone is an alternative if neither of those is tolerated.¹² The risk of a flare during dose escalation is particularly high if you had a flare in the month before starting the medication, so anti-inflammatory prophylaxis is especially worthwhile in that situation.¹¹

Many patients abandon urate-lowering therapy because of these early flares, assuming the drug is making things worse. Adherence to prescribed urate-lowering drugs ranges from only about 20% to 70%, among the lowest of any chronic condition.¹³ Understanding that early flares are expected and temporary can help you stick with the treatment that actually prevents long-term damage.

When Crystals Have Already Done Damage in the Hand

Even patients who have been on allopurinol for years can still have crystal deposits in their joints. One study of patients taking at least 300 mg of allopurinol daily for an average of five years found that about 69% still had detectable crystal deposits on advanced imaging. Among patients whose uric acid was actually under the target of 6 mg/dL and who had no palpable lumps, the rate was lower but still nearly 47%.¹⁴ This underscores that getting the uric acid level to target and keeping it there long term is essential for fully clearing crystal burden.

In the hand, crystal deposits that form visible lumps (tophi) can cause problems beyond pain. Tophi that develop along the flexor tendons of the fingers can prevent the fingers from straightening fully, mimicking a contracture. In one reported case, a tophus in the flexor tendon sheath grew large enough to compress the median nerve inside the carpal tunnel, causing numbness and tingling in the fingers along with a loss of finger extension. Surgery to remove the tophus restored full range of motion and resolved the nerve compression.¹⁵ Similar cases have been documented in younger patients, where an expanding tophus infiltrating the flexor tendons displaced the median nerve and caused classic carpal tunnel symptoms.¹⁶

All of these patients had gouty tophi on the same hand, confirming the link between long-standing crystal deposits and nerve or tendon complications.¹⁷ This is not common, but it is the kind of complication you can prevent entirely by keeping uric acid levels consistently below target.

Surgery for Severe Tophaceous Gout in the Hands

When tophi have caused significant deformity, pain, or loss of function in the hand, and medical therapy has not resolved the problem, surgery becomes an option. The main reasons for operating are deformity, chronic pain, and limited range of motion. After surgical resection, pain typically decreases, and function improves. However, the complication rate is not trivial, with about 28% of patients in one surgical series experiencing problems such as wound infection or wound dehiscence (the incision opening up).¹⁸

In cases where conservative treatment has been insufficiently effective, surgical removal of gouty nodules in the hand has resulted in significantly improved joint function, better cosmetic appearance, and higher quality of life.¹⁹ Surgery is a last resort, not a shortcut. It works best when combined with ongoing urate-lowering therapy to prevent new deposits from forming at the surgical site.

Diet and Lifestyle Changes That Actually Help

You cannot diet your way out of gout, but you can meaningfully lower flare risk and support whatever medication you are taking. The main dietary culprits are high-purine animal proteins (organ meats, red meat, certain shellfish), alcohol (especially beer), and drinks sweetened with high-fructose corn syrup.²⁰ A systematic review confirmed that high purine intake from animal sources, excessive alcohol, and obesity are all risk factors for gout flares.²¹

Dehydration raises uric acid levels by reducing the kidneys’ ability to flush it out, and crash diets or fasting can have the same effect by decreasing uric acid excretion.²² Drinking enough water throughout the day is one of the simplest things you can do to lower your baseline risk.

Cherries and cherry products have a dedicated following among gout patients. Research suggests they have anti-inflammatory and mild uric acid-lowering properties, and roughly a quarter of people with gout report using them as part of their management.²³ They are unlikely to replace medication for anyone with frequent flares, but they are a reasonable addition with minimal downside.

Medications That Can Trigger Flares

Some commonly prescribed drugs raise uric acid levels and can provoke gout attacks. Diuretics (both thiazide and loop types) are among the most frequent offenders. They reduce the kidneys’ ability to excrete uric acid, leading to a buildup in the blood.²⁴ Cyclosporine (used in transplant medicine) and even low-dose aspirin can also raise uric acid.²⁰

If you have gout and are prescribed a diuretic for blood pressure, it is worth a conversation with your doctor about whether an alternative could work. Sometimes switching the blood pressure medication is enough to tip the balance and reduce flares without adding another drug. This is especially relevant for people whose gout keeps recurring despite doing everything else right.

Gout Management With Kidney Disease

Gout and chronic kidney disease frequently coexist, and managing both at the same time can be tricky. The kidneys are responsible for excreting most of the body’s uric acid, so reduced kidney function means higher uric acid levels and more frequent flares. At the same time, many gout medications need dose adjustments or extra caution with impaired kidneys.²⁵

A common concern is that allopurinol doses are kept too low in kidney disease patients out of excessive caution, leading to undertreated gout. Current thinking supports a “start-low-go-slow” approach where the starting dose is low but is gradually increased while monitoring for side effects, rather than permanently capping the dose at an ineffective level.²⁵ Testing for the HLA-B*5801 gene before starting allopurinol is recommended for certain populations because carriers of this allele have a much higher risk of a severe hypersensitivity reaction.

For acute flares in people with severe kidney disease, colchicine at very low doses (no more than 0.5 mg per day in most cases) has been shown to be well tolerated and effective. In a study of patients with severe kidney problems, low-dose colchicine resolved the flare in about 83% of cases, and no serious side effects were reported.²⁶ NSAIDs are generally avoided in this population because they can further harm the kidneys.

Keeping Your Hands Warm

This sounds almost too simple, but temperature matters for gout in the hands more than in most other joints. Because uric acid crystallizes more easily in cooler environments, the hands and feet are naturally vulnerable. Cold exposure has been specifically identified as an environmental trigger that promotes monosodium urate crystallization.¹ Wearing gloves in cold weather, keeping your hands warm during outdoor work, and avoiding prolonged cold exposure are practical measures that cost nothing and complement every other part of your treatment plan. People who work with their hands in cold environments, from construction workers to commercial fishers, may find that addressing this one factor reduces flare frequency in the hands even before medication changes are made.

1
PubMed. Cold-Induced Gouty Arthritis: Exploring the Pathophysiological Link between Hyperuricemia and Gout Flare Triggers
2
PubMed. Crystal arthritides – gout and calcium pyrophosphate arthritis: Part 2: clinical features, diagnosis and differential diagnostics
3
Clinical Ultrasound. Musculoskeletal Ultrasound for Arthritis: Distinguishing Rheumatoid Arthritis, Osteoarthritis, and Gout
4
Annals of the Rheumatic Diseases. Dual-energy CT for the diagnosis of gout: an accuracy and diagnostic yield study
5
Annals of the Rheumatic Diseases. Open-label randomised pragmatic trial (CONTACT) comparing naproxen and low-dose colchicine for the treatment of gout flares in primary care
6
The Journal of Rheumatology. The Efficacy and Safety of Treatments for Acute Gout: Results from a Series of Systematic Literature Reviews Including Cochrane Reviews on Intraarticular Glucocorticoids, Colchicine, Nonsteroidal Antiinflammatory Drugs, and Interleukin-1 Inhibitors
7
PubMed Central. Intra‐articular glucocorticoids for acute gout
8
PubMed Central. Treatment Options for Gout
9
PubMed Central. Comparative Effectiveness of Allopurinol and Febuxostat in Gout Management
10
The Journal of Rheumatology. Clinical Efficacy and Safety of Successful Longterm Urate Lowering with Febuxostat or Allopurinol in Subjects with Gout
11
PubMed. Predicting Gout Flares in People Starting Allopurinol Using the Start-Low Go-Slow Dose Escalation Strategy
12
Rheumatology. Prophylaxis for acute gout flares after initiation of urate-lowering therapy
13
PubMed Central. Improving adherence to gout therapy: an expert review
14
BMJ Journals. Presence of monosodium urate crystal deposition by dual-energy CT in patients with gout treated with allopurinol
15
The Journal of Rheumatology. Finger Flexion Deformity and Carpal Tunnel Syndrome Caused by Gouty Tophus
16
PubMed. Carpal tunnel syndrome caused by gouty tophus of the flexor tendons of the fingers: sonographic features
17
Journal of Orthopaedics, Trauma and Rehabilitation. Carpal Tunnel Syndrome Caused by Gout: Clinical Presentations, Surgical Findings, and Outcomes after Surgery
18
PubMed. Surgical Management of Tophaceous Gout in the Upper Limb
19
PubMed Central. Tophi – surgical treatment
20
PubMed Central. Environmental Triggers of Hyperuricemia and Gout
21
PubMed Central. Impact of lifestyle factors and dietary patterns on serum uric acid levels and disease activity in gout: a systematic review
22
PubMed Central. Nonpharmacological Management of Gout and Hyperuricemia: Hints for Better Lifestyle
23
PubMed Central. Is there a role for cherries in the management of gout?
24
PubMed Central. Gout, diuretics and the kidney
25
PubMed. Gout Management in Patients With CKD: A Review
26
RMD Open. Safety and efficacy of colchicine in crystal-induced arthritis flare in 54 patients with severe chronic kidney disease